Galapagos NV (AMS:GLPG) Upgrade of Rating

Galapagos NV (AMS:GLPG) was upgraded by stock research analysts at Janney Capital from Sell rating to Neutral rating in a research report revealed to clients and investors on Friday, 7 July.

The stock upgrade is well-received by stock investors, as AMS:GLPG is currently trading 1.66% higher at $66.88 as of 2:05 AM New York time. Galapagos NV’s stock is 0% over the last 200 days. It has underperformed the S&P500 Index, which has risen 6.00% over the same time period.

Galapagos NV (AMS:GLPG) Profile

Galapagos NV is a Belgium-based biotechnology company. The Company’s activities are divided into two operating divisions: Research and Development (R & D) and Services. The R & D division is engaged in the discovery and development of small molecules.

Galapagos NV (AMS:GLPG) traded up 1.66% on 7 July, hitting $66.88. A total of 446,082 shares of the company’s stock traded hands. This is down from average of 524,916 shares. Galapagos NV has a 52 week low of $46.06 and a 52 week high of $89.75. The company has a market cap of $3.40B and a P/E ratio of 1173.75.

Get the latest Galapagos NV (AMS:GLPG) Stock Ratings at Octafinance. Completely free access to our Analyst Ratings Database for 6000+ stocks.

The post Galapagos NV (AMS:GLPG) was Upgraded at Janney Capital from a Sell Rating to Neutral Rating appeared first on Octafinance.